As we navigate the spread of COVID-19, we remain committed to serving our healthcare providers in the most impactful way we can. We are pleased to offer a COVID-19 diagnostic test for in-clinic use. Our test is performed with RT-PCR technology, the current preferred testing method of the Centers for Disease Control (CDC). By identifying the RNA of the virus, our test specifically detects SARS-CoV-2 virus in patients’ cells.
In addition to identifying COVID-19 in a patient that is presenting symptoms, our test can be a helpful tool to track the progression of the disease and confirm when a patient is virus-free.
*Our test is typically eligible for insurance reimbursement or government reimbursement under the Families First Coronavirus Response Act. US BioTek Laboratories does not submit tests for reimbursement, but we do deliver CPT codes and superbills so patients or practitioners can submit for insurance reimbursement.
We use real-time reverse transcription polymerase chain reaction (RT-PCR) tests to qualitatively detect nucleic acid from SARS-CoV-2, as recommended by the CDC. The RT-PCR platform is FDA-authorized and requires specialized equipment and personnel to identify the virus RNA within cells. This type of testing is considered more accurate than most “rapid” tests. The specificity of the RT-PCR is tested weekly to ensure that newly discovered COVID-19 mutations are detected by the test.
Polymerase chain reaction (PCR) is a relatively simple and widely used molecular biology technique to amplify and detect DNA and RNA sequences. PCR is a highly sensitive method and uses very small volumes for single reactions and to rapidly make millions to billions of copies of a specific RNA sample allowing scientists to take a very small sample of RNA and amplify it to a large enough amount to study in detail.
Reverse transcription PCR (RT-PCR) is used when the starting material is RNA. In this method, RNA is first transcribed into complementary DNA (cDNA) by reverse transcriptase. The cDNA is then used as the template for the polymerase chain reaction.
Once the specimen has been received by our lab, you can expect test results in 2-3 days. You will be able to view the results via our online portal.
At this time the FDA has not yet approved any at-home testing methods, so we are only able to offer our COVID-19 diagnostic test to medical providers for in-clinic use.
We are a CLIA accredited medical laboratory based in Shoreline, Washington. We employ the latest laboratory technology, advanced automation, and a dedicated research team to ensure the accuracy and reproducibility of every test. We've applied 30+ years experience in laboratory science to refine and optimize the procedures we follow in our tests, resulting in more meaningful and reliable information for providers and patients.
How To Order:
Fill out and submit the form below to request COVID-19 diagnostic tests. You will need a US BioTek account to place an order. If you do not yet have one, please click here sign up for an account.
Once you submit the form below, our team will reach out to you to finalize your account with payment details.
Please note that due to limited tests, we will fulfill orders on a first-come, first-served basis. We will do our best to fulfill all order requests.